MoneyWorks4Me

Abbott India informs about change in management

22 Apr 2026 Evaluate
Abbott India has informed about following outcome of the Board Meeting held today i.e., April 22, 2026. Anisha Motwani (DIN: 06943493), Independent Director, will be completing her second term as an Independent Director of the Company on April 24, 2026. Accordingly, she ceases to be the Director of the Company with effect from the close of business hours on April 24, 2026. Details pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 (SEBI Circular), is enclosed as Annexure; Appointment of Neeraj Jain (DIN: 00348591) as an Additional Director designated as an Independent Director, with effect from April 25, 2026; etc.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..